SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-094652
Filing Date
2011-11-03
Accepted
2011-11-03 10:00:20
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q b87811be10vq.htm 10-Q 347721
2 EX-31.1 b87811bexv31w1.htm EX-31.1 8079
3 EX-31.2 b87811bexv31w2.htm EX-31.2 8445
4 EX-32.1 b87811bexv32w1.htm EX-32.1 4048
5 EX-32.2 b87811bexv32w2.htm EX-32.2 4147
  Complete submission text file 0000950123-11-094652.txt   1594318

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT crtx-20110930.xml EX-101.INS 181176
7 EX-101 SCHEMA DOCUMENT crtx-20110930.xsd EX-101.SCH 8478
8 EX-101 CALCULATION LINKBASE DOCUMENT crtx-20110930_cal.xml EX-101.CAL 33250
9 EX-101 LABELS LINKBASE DOCUMENT crtx-20110930_lab.xml EX-101.LAB 109406
10 EX-101 PRESENTATION LINKBASE DOCUMENT crtx-20110930_pre.xml EX-101.PRE 68432
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50767 | Film No.: 111176375
SIC: 2834 Pharmaceutical Preparations